Product
DOR + FTC/TAF
1 clinical trial
8 indications
Indication
Body Weight ChangesIndication
HIVIndication
Antiretroviral TherapyIndication
ObesityIndication
Minority healthIndication
BMDIndication
Metabolic SyndromeIndication
FastingClinical trial
Effect of Modified, Rapid-start, DOR/3TC/TDF or DOR + FTC/TAF or BIC/FTC/TAF on Body Weight and Composition, Metabolic Risk Parameters, and Measures of Bone Strength in Treatment-Naïve Black and Hispanic Women With HIV-1 InfectionStatus: Withdrawn, Estimated PCD: 2023-05-03